Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP688268.RAVh-Q9JIG1-eNE3AiEGiTyNdwleRjaYdJpLEu2m9C6_g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP688268.RAVh-Q9JIG1-eNE3AiEGiTyNdwleRjaYdJpLEu2m9C6_g130_assertion type Assertion NP688268.RAVh-Q9JIG1-eNE3AiEGiTyNdwleRjaYdJpLEu2m9C6_g130_head.
- NP688268.RAVh-Q9JIG1-eNE3AiEGiTyNdwleRjaYdJpLEu2m9C6_g130_assertion description "[Further understanding of the CXCR4/CXCL12 pathway in SCLC and NSCLC may provide a rationale for innovative research on the CXCR4 receptor as a potential novel therapeutic target in lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP688268.RAVh-Q9JIG1-eNE3AiEGiTyNdwleRjaYdJpLEu2m9C6_g130_provenance.
- NP688268.RAVh-Q9JIG1-eNE3AiEGiTyNdwleRjaYdJpLEu2m9C6_g130_assertion evidence source_evidence_literature NP688268.RAVh-Q9JIG1-eNE3AiEGiTyNdwleRjaYdJpLEu2m9C6_g130_provenance.
- NP688268.RAVh-Q9JIG1-eNE3AiEGiTyNdwleRjaYdJpLEu2m9C6_g130_assertion SIO_000772 20147779 NP688268.RAVh-Q9JIG1-eNE3AiEGiTyNdwleRjaYdJpLEu2m9C6_g130_provenance.
- NP688268.RAVh-Q9JIG1-eNE3AiEGiTyNdwleRjaYdJpLEu2m9C6_g130_assertion wasDerivedFrom befree-20150227 NP688268.RAVh-Q9JIG1-eNE3AiEGiTyNdwleRjaYdJpLEu2m9C6_g130_provenance.
- NP688268.RAVh-Q9JIG1-eNE3AiEGiTyNdwleRjaYdJpLEu2m9C6_g130_assertion wasGeneratedBy ECO_0000203 NP688268.RAVh-Q9JIG1-eNE3AiEGiTyNdwleRjaYdJpLEu2m9C6_g130_provenance.